Talk:Otamixaban
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Otamixaban.
|
Lancet[edit]
doi:10.1016/S0140-6736(09)61454-9 - head to head with UFH & 2b3a (eptifibatide). This was mainly an efficacy/safety study, and the abstract suggests that phase III trials will probably happen now. I'm not entirely sure why one would use an intravenous anticoagulant rather than LMWH, and nor am I clear why this phase II trial went into the Lancet. But there we are, and it is probably notable enough to be discussed here. JFW | T@lk 11:06, 6 September 2009 (UTC)